|
|
||||||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
1
Department of Physiology and Biophysics, University of Colorado Health Sciences Center, Denver, CO 80262
2 Department of Pediatrics, National Jewish Medical and Research Center, Denver, CO 80206, USA
| Abstract |
|---|
|
|
|---|
(Received 29 May 2004;
accepted after revision 29 July 2004;
first published online 5 August 2004)
Corresponding author M. C. Neville: Department of Physiology and Biophysics, Room 2802-2, Box C240, University of Colorado Health Sciences Center, Denver, CO 80262, USA. Email: peggy.neville{at}uchsc.edu
| Introduction |
|---|
|
|
|---|
Although vesicular albumin transport across elements of the mesothelium seems clear (Vogel et al. 2001; Bodega et al. 2002), the transfer of albumin across epithelial barriers was long thought to represent non-specific transfer of protein through the paracellular pathway. However, in recent studies Malik and co-workers (Kim & Malik, 2003) identified a luminal-to-interstitial space pathway in the lung that is abolished both by crosslinked antibodies to gp60 and by filipin, a drug that rapidly disrupts caveoli. In the mammary gland the presence of albumin in milk, when observed, was taken as evidence that mammary tight junctions were open and that the paracellular pathway was freely permeable even to large proteins (Schanbacher & Smith, 1975; Grigor et al. 1991). However, evidence that mouse milk contains a concentration of albumin approximately equal to that of plasma (Halsey et al. 1982) together with data from this and other laboratories indicating that the tight junctions of the mammary epithelium are impermeable during lactation (Linzell & Peaker, 1974; Berga, 1984; Nguyen et al. 2001) prompted us to examine the proposition that albumin is transported by transcytosis across the mammary epithelium into mouse milk. Because no in vitro mammary epithelial system currently exists that transcytoses albumin, it was necessary to devise techniques to study albumin transfer in vivo. We used these techniques to re-evaluate the pathway by which the enormous amount of albumin in mouse milk is transferred across the epithelium and to test the hypothesis that this transport is mediated by caveolar uptake at the basal surface of the cell. Our results show that albumin is indeed transcytosed across the mammary epithelial cells, and the pathway appears to utilize the well-studied IgA transcytotic pathway (Kraehenbuhl & Hunziker, 1998) providing evidence for a novel mechanism for albumin transcytosis across an epithelial layer.
| Methods |
|---|
|
|
|---|
125I sodium iodide was obtained from ICN; Iodobeads, NHS-fluorescein, NHS-rhodamine, DNP-X-SE, from Pierce; rabbit anti-mouse albumin (for ELISA) and mouse albumin protein standards from Accurate Chemical & Scientific Corp.; fluorescent secondary antibodies and normal donkey serum from Jackson Immunoresearch; JB-4 resin components from Polysciences, Inc.; mice from Charles River laboratories; Cell-Tak from Collaborative Biomedical; slides (Superfrost/Plus) and coverslips (No. 1) from Fisher Scientific; Hybond C, nitrocellulose membrane from Amersham; rabbit anti-mouse albumin (for ELISA capture, and immunostaining) and goat anti-mouse IgA(
-chain) from ICN/Cappell; rabbit anti-caveolin-1(N-20), goat anti-clathrin HC(C-20) and goat anti-caveolin-2(N-20) from Santa Cruz Biotechnology; rabbit anti-dinitrophenyl-KLH, rabbit anti-fluorescein and Alexa 488 conjugate, from Molecular Probes. Rabbit anti-mouse ß-casein (AB # 7781) was prepared in this laboratory. All other chemicals were from Sigma Chemical Company.
Mice
CD1 mice were housed in the University of Colorado Health Sciences Center USDA-approved animal quarters. All mice were anaesthetized with sodium pentobarbital (0.1 mg (g body weight)1) prior to killing by cervical dislocation or perfusion with saline and fixative (see Methods below). Day 1 of lactation was designated the day the pups were born. At birth, litters were standardized to 10 pups. All experiments were performed in mid-lactation (between days 7 and 14) with most performed on day 10. The Institutional Animal Care and Use Committee of the University of Colorado Health Sciences Center approved all procedures which follow the guidelines of the United States Department of Agriculture.
Albumin transport from bloodstream
Mouse albumin (Sigma, fraction V) was labelled with radioactive iodine (Na125I, ICN) using the Pierce iodobead kit. 125I-albumin was extensively dialysed against PBS and used for experiments within 24 h. Three mice at a time were injected with 100 µl 125I-albumin in Ringer solution (1 mg ml1, 0.180.27 mCi mg1). Timing of the experiment was based on a study of low-density lipoprotein (LDL) transport across the mammary epithelium wherein 7 h were required for steady state levels of labelled LDL, transported from the blood stream, to be achieved (Monks et al. 2001). From t = 58 h after injection the mice were anaesthetized and the right mammary gland exposed and incubated in situ with 2 ml of Ringer solution as described for the interstitial space preparation (ISSP) below. Samples of blood, serum, whey and mammary gland were collected at 8 h, proteins were precipitated from these samples, as well as the initial substrate and the ISSP solution with 10% trichloroacetic acid and the precipitates were subjected to gamma counting. Additionally, the concentration of albumin in samples of serum, whey, ISSP, homogenized mammary gland and liver, was determined by enzyme-linked immunosorbent assays (ELISA) for mouse albumin (Igarashi et al. 1993). ELISA data and gamma counts were used to determine specific activities. Additional samples from these tissue fractions were separated by SDS-PAGE, immunoblotted for endogenous mouse albumin, and exposed to X-ray film to visualize the 125I-albumin probe.
Interstitial space preparation
The interstitial space preparation (ISSP) was developed to gain experimental access to the interstitial fluid of the lactating mouse mammary gland. A female mouse at mid-lactation was anaesthetized with sodium pentobarbital (0.1 mg (g body weight)1 with 1 mg boosts as necessary). Upon loss of toe-pinch reflex, the mouse was laid on her back, a midline incision was made on the abdomen, and the abdominal skin was pulled back to reveal the fourth and fifth mammary glands attached to the skin. The skin was cupped and pinned to allow overlay of 12 ml of Ringer phosphate buffer with 0.5% fetal calf serum, and addition of probe(s) of interest on the exposed glands as necessary. After 24 h of incubation, during which the mouse was kept warm and the open abdomen moist, the bath solution was collected and the exposed tissue rinsed quickly with buffer (+ FCS). The mouse was then subjected to intracardiac perfusion with Ringer solution at a rate of 6 ml min1 for 5 min, followed by 2%, then 4% paraformaldehyde in Ringer solution, pH 7.4 (4°C, 30 ml each). The exposed mammary tissue (and control gland) were then dissected and processed for embedding in JB-4 resin (for fluorescently labelled, fixable probes) or frozen (for immunofluorescent staining).
For JB-4 embedding, the tissue was further immersion fixed for 4 h in 4% paraformaldehyde, then washed in 50 mM NH4Cl, 0.1 M phosphate pH 7.0, first with, then without 2% sucrose. The tissue was dehydrated in 75% and 100% acetone, then infused with JB-4 component A, then A + component C, and then embedded (Beckstad, 1985). For frozen sections, the dissected tissue was sandwiched between aluminium foil (to prevent organic extraction) and quickly frozen in isopentane (2-methyl-butane) cooled to freezing with liquid nitrogen. Frozen tissue was then stored at 70°C up to several months, to await sectioning. Freshly sectioned tissue was subsequently vapour-fixed with paraformaldehyde for 15 min, and either mounted or processed further.
Introduction of fluorescent probes into the mammary duct or interstitial space
Fluorescein was conjugated to mouse albumin (fraction V) using the NHS-FITC kit according to manufacturer's instructions. Similarly, mouse apo-transferrin was rhodamine-labelled using NHS-TRITC. Probes at a concentration of about 1 mg ml1 were extensively dialysed against Ringer solution, sterifiltered and stored at 4°C until use. For intraductal injection one lactating mouse was removed from her pups and anaesthetized with Avertin (0.8 mg (g body weight)1, with 10 mg boosts as necessary). Using a pulled and fire-polished capillary pipette (o.d.
70 µm (Nguyen et al. 2000) 80 µl of FITC-labelled albumin was injected up one teat. The mouse was allowed to recover. After 2 h the mouse was anaesthetized with pentobarbital (0.1 mg (g body weight)1), perfused as above, and the mammary gland dissected and processed. For the ISSP, a 1 mg probe was added to 2 ml of ISSP bath solution. After a 2 h incubation the mouse was perfused as described above, and the gland processed for embedding in JB-4 and/or freezing.
Immunostaining
Ten-micrometre sections were cut from frozen blocks on a Damon/IEC division minotome set at 18 to 20°C. Sections were collected onto Cell-Tak-coated coverslips and vapour fixed with paraformaldehyde for 15 min. Sections were never allowed to dry. Tissue was permeabilized with 1% Triton X-100 for 15 min, rinsed with PBS and blocked with 10% normal donkey serum. Primary antibodies were diluted in PBS to achieve the following concentrations: 40 µg ml1 rabbit anti-mouse albumin, 20 µg ml1 goat anti-mouse IgA, 20 µg ml1 rabbit anti-caveolin-1, 20 µg ml1 goat anti-caveolin-2, 10 µg ml1 goat anti-clathrin, and incubated with frozen sections for 1 h, followed by extensive washes in PBS. Fluorescein-, Cy3- or Cy5-labelled secondary antibodies, all made in donkey and cross-adsorbed against mouse serum, were diluted according to manufacturer's instructions and combined with 0.6 µg ml1 DAPI. After a 1 h incubation with secondary antibodies, the sections were rinsed briefly and allowed to soak overnight in PBS. Coverslips were mounted with anti-fade mounting medium (20 mg ml1 o-phenylenediamine in TBS, pH 8.5, diluted 1: 10 with glycerol), sealed with clear nail polish and stored at 20°C until imaging.
Because the primary antibodies for albumin and casein were both made in rabbit, they needed to be haptenylated for co-immunostaining. Briefly, rabbit anti-mouse ß-casein IgG was precipitated with caprylic acid and labelled with DNP-X-SE according to manufacturer's instructions. Rabbit anti-mouse albumin was labelled with NHS-FITC and rabbit anti-dinitrophenyl-KLH was labelled with NHS-TRITC. After labelling, antibody dilutions were retitred. Rabbit anti-fluorescein, Alexa 488 conjugate was used to enhance the FITC-rabbit anti-mouse albumin stain.
Inhibition of albumin transcytosis
Endocytic inhibitors were used in the ISSP at the following concentrations: filipin (500 µg ml1), chlorpromazine (500 µg ml1), N-ethylmaleimide (NEM, 5 mM), or an equivalent volume of dimethylsulfoxide (DMSO) carrier alone. After 15 min pre-incubation with bath solution containing the appropriate inhibitor, FITC-labelled albumin and TRITC-labelled transferrin were added in fresh bath solution with inhibitor. After 1.5 h the gland was rinsed with unlabelled bath solution for 5 min, the mouse was perfused as previously described and the tissue was frozen for sectioning. We chose this time period because it was sufficient to observe labelled probe in the lumen of surface alveoli, implying that vesicles within the cytoplasm were labelled at steady state.
Fluorescence imaging methods
Images were collected, processed and analysed using SlideBook software (Intelligent Imaging Innovations, Inc.) on a Nikon Diaphot TMD microscope equipped for fluorescence with a Xenon lamp and filter wheels (Sutter Instruments), fluorescent filters (Chroma), cooled CCD camera (Cooke) and stepper motor (Intelligent Imaging Innovations, Inc.). Three adjacent z-sections were collected and deconvolved using a Nearest Neighbours algorithm (Agard, 1984). Multi-fluor images were merged and renormalized. Positive staining was defined as twice tissue background. Vesicles were hand-delineated for counting and quantification of colocalization.
| Results |
|---|
|
|
|---|
The albumin in serum from non-pregnant, non-lactating mice, 10 day lactating mice, as well as in their milk was quantified by ELISA. The results (Table 1) confirm earlier data of Halsey et al. (1982) and show, not only that the ratio of the albumin concentration in milk to that in serum is indistinguishable from unity, but also that the concentration of albumin in the serum is reduced by 50% or more during lactation.
|
|
Albumin transport across the mammary epithelium in vivo
To verify that a paracellular transport pathway does not account for the albumin in milk, we examined passage of albumin from the lumen to the interstitial space, injecting FITC-labelled murine albumin into the mammary duct. Figure 2A shows the localization of FITC-labelled mouse albumin 2 h later. Stain was confined to the lumen, absent from the interstitial space and from intracellular vesicles. In another experiment, FITC-labelled mouse albumin was added to Ringer solution bathing the in vivo mammary gland using the interstitial space preparation (see Methods; Monks et al. 2001). After 4 h, the lumina were heavily stained (Fig. 2B). Consistent with earlier work in this laboratory (Nguyen et al. 2001), the results of this experiment indicate that albumin is excluded from the paracellular pathway and that albumin is transported preferentially in the basal-to-apical direction via a transcytotic pathway. Similar results were obtained when Texas Red-labelled dextran and horseradish peroxidase were added to the interstitial medium (see Fig. 1, Supplementary Material) suggesting the presence of a fluid phase transport pathway.
|
In epithelial cells in culture, where the process has been studied in detail, both transferrin and the transcytosed protein IgA are taken up by a clathrin-coated endocytic vesicles and transported to a basal early endosome. There transferrin is sorted for recycling to the basal surface, fluid phase substrates are sorted to the lysosome for degradation, and the IgA is transcytosed to be secreted at the apical surface (Apodaca et al. 1994; Tuma & Hubbard, 2003). Figure 3 shows low and high power views of sections of glands incubated for 2 h with both FITC-labelled murine albumin and rhodamine-labelled murine transferrin using the ISSP technique in vivo. At low magnification (Fig. 3A) it is clear that albumin and transferrin are differentially localized. While substantial amounts of albumin are present in the lumen of each alveolus, transferrin is seen primarily near the basolateral surface of the epithelium. Even at high magnification (Fig. 3B) surprisingly little albumin is colocalized with transferrin, although occasional cytoplasmic vesicles (arrows) containing both probes can be seen in regions away from the basal membranes. At the basal surface of the cell where one would expect the early endosomes, transferrin and albumin show a patchy distribution with very little overlap (asterisk). The putative early endosomes and recycling compartments containing transferrin are visible just inside the basal membrane, but they appear to exclude albumin, which shows its own patchy distribution in the same basal region. When the basal membrane is viewed en face as shown in Fig. 3C, it appears to possess localized microdomains, which bind either albumin or transferrin, indicating sorting right at the basal surface. Whether this sorting occurs at the plasma membrane or just inside it as predicted by results in cultured cells, cannot be told at this magnification. However, most of the transferrin-containing compartments just inside the membrane do not contain albumin as seen in the cross-sectional view at the upper left of this figure. The limited overlap that can be discerned may represent the early endosome prior to sorting of albumin and transferrin or may represent separate vesicles below the resolution of the light microscope, even with digital deconvolution. In either case a large amount of FITC-labelled albumin is arrayed near the basal surface of the cell. The indentation labelled m in Fig. 3Bc, and enlarged in the inset, represents the process of a myopithelial cell, a structure which lies within the basal lamina (dotted line in inset). Both transferrin and albumin localize around this structure suggesting that they are bound to or internalized at the basal membrane of the epithelial cell and not simply adsorbed to the basal lamina.
|
To determine whether transcytosis of albumin involves the secretory compartment, sections of a mammary gland from a lactating mouse were stained for endogenous albumin and beta-casein (Fig. 4). Endogenous albumin shows a distribution similar to that of the exogenous albumin shown in Figs 2 and 3, with heavy staining at the basal border, intracellular vesicles and a capillary (C). The discontinuities of stain at the basal surface are less apparent, in part because the frozen sections necessary for antibody interactions with cellular protein are thicker than the plastic sections used to examine fluorescent probes applied from the interstitial space. Dense stain for casein is present in large irregular compartments presumably representing the expanded trans-Golgi sacs of the lactating mammary cell (Clermont et al. 1993). Fainter stain is seen in more diffuse regions throughout the cell presumably representing the rough endoplasmic reticulum. There is insignificant (less than 4% using the masking programs of SlideBook) overlap between casein and albumin, indicating that the transcytotic pathway through which albumin traverses the cell is entirely distinct from the secretory compartment responsible for secretion of casein and other milk proteins into the lumen.
|
We explored the distribution of caveolin in mammary epithelial cells, immunostaining frozen sections of mammary gland from a lactating mouse for caveolins 1 and 2. Anti-caveolin-1 brightly stains myoepithelial cells (arrows, Fig. 5A and B), capillary endothelium and interstitial adipocytes (data not shown), all of which have morphologically distinct membrane caveolae in electron micrographs (Supplementary Material, Fig. 2; Elias et al. 1973). Mammary alveolar cells themselves do not possess morphologically distinct caveolae, but they do express both caveolin-1 and caveolin-2 (Fig. 5A). Both proteins appear to be present near or on basolateral plasma membranes and in punctate structures in the apical cytoplasm with diffuse staining over the apical region of the cell. While both proteins appear to be present on the basolateral membrane, in the merged diagram green and red regions of stain are largely distinct at the membrane as well as throughout the cytoplasm. To obtain a more quantitative picture of colocalization of the two caveolins in vesicular structures, we used the masking function of SlideBook to define the intensity and volume of Cy3- and FITC-labelled regions, selecting regions between 10 and 75 pixels in volume that had intensities greater than twice the background. The mean intensities of the selected regions are plotted in Fig. 6A showing the intensities of structures stained for caveolin-1 and caveolin-2. Most intracellular vesicles contain either caveolin-1 (62%) or caveolin-2 (29%) with only about 9% of the vesicles staining for both proteins. These 9% may represent a real subpopulation of vesicles containing both proteins, or they may have been scored as such because two closely spaced vesicles were not resolved at the resolution of these images (
200 nm).
|
|
To confirm this finding we examined the effect of filipin, an agent that has been demonstrated to remove caveolin-1 from membranes resulting in diffuse cytoplasmic staining and morphological flattening of membrane structures (Schnitzer et al. 1994). Addition of filipin to an interstitial space preparation containing FITC-labelled albumin for a 2 h incubation resulted in subtle changes of staining patterns of both caveolin-1 and caveolin-2 (Fig. 5D and not shown). The number of FITC-labelled vesicles within cells selected from surface alveoli on the basis of a large basally located nucleus and clearly evident basal surface was counted. There was no statistical difference between vehicle-treated controls and filipin-treated cells (Fig. 6B). Thus, filipin treatment resulted in no reduction in the number of intracellular vesicles containing FITC-labelled albumin providing additional evidence that caveolin-containing vesicles are not involved in albumin transfer across the mammary epithelium.
Does albumin utilize the same pathway as IgA to cross the mammary epithelium?
The pathway for transfer of IgA across the mammary epithelium via binding to the polymeric immunoglobulin receptor (pIgR) has been well described (Kraehenbuhl & Hunziker, 1998). IgA binds to the pIgR and is internalized via clathrin-coated vesicles followed by sorting of the IgApIgR complex for transcytosis in the endosomes. As shown in Fig. 7, albumin appears to be colocalized with IgA in punctate regions within the cell, although the stains are largely separate at the basal surface where IgA appears to be localized closer to or within the membrane and the albumin localized more distally. The domains of the stain appear to be distinct in at least a part of the membrane region. Within the cell the albumin stain appears to overwhelm the IgA stain, as might be expected since about 30 times as much albumin is transported into mouse milk as IgA. Milk IgA is 0.59 ± 0.32 mg ml1 (Hendrickson et al. 1996) compared with albumin values of about 20 mg ml1 (Table 1). Nonetheless, a scattergraph showing the intensities of albumin and IgA stain at each of 140 points within the cells shows that the two are colocalized throughout the cell (Fig. 7D).
|
|
| Discussion |
|---|
|
|
|---|
We then examined the pathway by which albumin traverses the mammary epithelium using two newly developed in vivo techniques that allow us to bring fluorescent tracers directly in contact with the apical and basal surfaces of the epithelium. With intraductal injection we confirmed our earlier finding (Nguyen et al. 2001) that tracers, including FITC-labelled albumin, injected into the lumen of the mammary gland during lactation stay confined to this compartment, ruling out the possibility of flux through the paracellular pathway. On the other hand, FITC-labelled albumin and other fluid phase markers placed in the interstitial space found their way to the lumen in large quantities and albumin itself was visible as punctate spots within the cytoplasm. Additionally its localization differed from that of Cy3-labelled transferrin, which was mostly visible in a recycling compartment just beneath the basal membrane of the cell, although we have shown elsewhere (Zhang et al. 2000) that a small amount is transcytosed. A total lack of colocalization of endocytosed albumin with casein indicated that the transcytotic pathway does not intersect the very active protein secretory pathway also present in the lactating epithelium.
Our initial hypothesis, borrowed from transcytosis of albumin in the capillary endothelium (Minshall et al. 2002) was that albumin bound to one or more glycoproteins localized to membrane caveoli and was transcytosed in caveolar vesicles. The finding that both caveolin-1 and -2 are present in mammary epithelial cells, albeit at levels much lower than myoepithelial cells or capillaries (Fig. 5), supported this hypothesis. However, the punctate structures in the cytoplasm of the alveolar cells that contain endocytosed albumin or stain for endogenous albumin do not colocalize with either caveolin-1 or -2, and filipin, an antibiotic that disrupts caveoli, does not affect the localization of these structures. These observations are not compatible with caveolar transport of albumin across the mammary epithelium. It should be noted that albumin did colocalize with caveolin in the capillary endothelium of the mammary gland (data not shown) suggesting that, as in other organs (Schnitzer et al. 1994; Vogel et al. 2001), albumin is transported across the capillary endothelium in caveolar vesicles. Caveolin-1 null mice have been generated, and while the mammary glands show premature initiation of lactation during pregnancy apparently because caveolin down-regulates prolactin signalling, no mention was made of abnormalities during lactation (Park et al. 2002).
We found that albumin does colocalize with another transcytotic marker, IgA, in vesicular structures and, consistent with this finding, albumin endocytosis was sensitive to pharmacological agents that disrupt clathrin-mediated endocytosis. Chlorpromazine is a cationic amphiphilic drug, which inhibits receptor-mediated endocytosis by inhibiting the assembly of clathrin and AP-2 at the coated pit. NEM-sensitive factors, soluble ATPases, are involved in assembly of NSF/SNAP/SNARE complexes necessary for all types of vesicle trafficking studied to date (Lamaze & Schmid, 1995; Mukherjee et al. 1997; Clague, 1998). Both chlorpromazine and NEM inhibited albumin uptake by lactating mammary epithelial cells in situ. We conclude that albumin is transported via a clathrin-mediated endocytic pathway. Further most of the albumin avoids being routed to lysosomes and degraded, although the finding that endogenous albumin fragments in the alveolar cell (Fig. 1) may indicate that there is some intracellular degradation.
To get from the blood stream albumin must pass first through the capillary barrier, then the interstitial space, and finally the basement membrane to come into proximity with the basal surface of the epithelial cell. Here albumin probably gives up some of its transported molecules such as fatty acids, trace elements and hydrophobic hormones. Unless it is transcytosed or modified to become a target for degradation, albumin must be transported back to the blood stream either by re-entering the capillary or entering the lymphatic circulation. Interestingly, the capillaries show extremely heavy uptake of FITC-labelled albumin from the interstitial space (Fig. 4) as well as uptake of gold-labelled albumin into vesicular structures in the endothelium (see Supplemental Material, Fig. 2). While luminal to basal transcytosis of albumin has been demonstrated in many endothelial systems (Minshall et al. 2002), our observation suggests that albumin also returns from the interstitial space to the capillary lumen via a transcytotic process. If this is the case, the lymphatic circulation, although known to be extensive in the mammary gland (Lascelles, 1977; Davis et al. 1992), is probably not responsible for returning all the albumin that enters the interstitial space to the plasma.
Albumin, whether measured by uptake of FITC-labelled protein or by immunohistochemistry, is associated in a heavy layer at the basal surface of the cell clearly segregated from transferrin and possibly segregated from IgA as well. A possible explanation for this unexpected observation is that albumin uptake may be dissociated from transferrin recycling at the plasma membrane rather than in the early endosome as in the tissue culture systems where transcytosis has been most extensively defined (Mostov, 1993). However, other explanations are possible. For example, albumin may associate with regions of the basal surface or basement membrane as it transfers fatty acids to the alveolar cell, whereas smaller amounts may be endocytosed with transferrin in another region of the basal surface. The finding that the heavy binding of albumin is apparently dissociated from IgA binding at the basal surface, while it is uniformly associated with IgA transport within the cytoplasm, is consistent with this notion. Unfortunately, the heavy binding of all of these molecules at the basal surface of the cell and the lack of good anti-mouse transferrin antibodies precluded further analysis of this problem using fluorescence. When we attempted to use gold-labelled albumin at the electron microscope level to resolve the issue, we found probe associated with the capillary endothelium and in macrophages, but insignificant amounts were associated with the basal regions of the mammary epithelial cells (see Supplementary Material, Fig. 2). We suspect the reason to be that gold-labelled albumin associates preferentially with scavenger receptors and is not seen by the endocytotic pathway in the alveolar cells themselves.
Many questions remain, the most important of which is whether albumin transport across the mouse mammary epithelium is receptor-mediated or a function of fluid phase endocytosis. Putative receptor-mediated transport of albumin across epithelia has been described in rat jejunum (Kimm et al. 1997), the lung epithelium (Kim & Malik, 2003), and bile canniliculi (Sztul et al. 1983). The last observation is the most interesting because the vesicle mediators of albumin transcytosis from the space of Disse in rat liver to the bile canniliculi have been shown to contain both albumin and IgA bound to pIgR (Barr et al. 1995; Pol et al. 1997); however, in this system much less albumin is transported than IgA, making fluid phase transport more plausible than in the mammary gland.
Unfortunately, we found that most traditional solutes such as non-metabolizable sugars and dextrans used to study fluid-phase transport were rapidly excreted by the kidney so that steady state ratios could not be measured under our experimental conditions. A potential measure of fluid-phase movement across mammary epithelium is given by the transport of monomeric IgA into the milk of J-chain-deficient mice (Hendrickson et al. 1996) where a steady-state milk/serum ratio of 0.21 can be calculated from the data. (The ratio is 4.2 in wild type mice where the polymeric IgA receptor binds the J-chain.) This is only one/fifth of the steady state plasma/milk ratio for albumin of about unity. Further, if albumin transport occurs by fluid phase transfer and the concentration of albumin in the interstitial space is equal to that of the plasma, the implicaton is that a volume of interstitial fluid equal to that of the secreted milk must be engulfed at the basal surface and the proteins concentrated as fluid and ions are removed from the endocytic vesicles during their transfer across the cell. The volumes involved are not impossible, amounting to less than 6% of the cell volume per hour. On the other hand, if albumin is concentrated in the region of the basal surface of the cell by binding, for example, to a fatty acid transporter, then this adsorptive transport could involve much smaller fluid volumes.
What are the implications of this transcytotic pathway for the lactating dam and her pups? It is unclear whether the lactational hypo-albuminaemia seen in mice is an adaptive mechanism to provide specific beneficial metabolic changes or whether it is a direct result of increased clearance of albumin from the system by the mammary gland. The lowered concentration of albumin is probably balanced by an increase in circulating immunoglobulins and apoB-containing lipoproteins (Monks et al. 2001). A similar compensation is seen in humans with hypo-albuminaemia (Maugeais et al. 1997). Similar changes in serum proteins are not seen in lactating females of other species including rats, ruminants or humans, probably because the concentration of albumin in the milks of these species (5, 0.4 and 0.4 mg ml1, respectively; (Geursen & Grigor, 1987; Lonnerdal & Atkinson, 1995; Swaisgood, 1995) is much lower than in mice.
Mouse pups are born in a very immature state and unlike tricial mammals are unlikely to possess endogenous stores of trace elements and fat-soluble vitamins sufficient for their rapid growth during the suckling period (less than 3 weeks). Under these circumstances albumin may function to deliver such substances directly to the pups without the need for elaborate transport mechanisms for each of these substances. Although the concentration of albumin in human and cow's milk is very much lower, the existence of a similar transcytotic pathway in the human mammary gland could allow the transport into milk of any substance that finds its way into the interstitial space. Such a mechanism could, for example, account for the presence of cow's milk proteins in certain samples of human milk.
| Supplementary material |
|---|
|
|
|---|
DOI: 10.1113/jphysiol.2004.068403
http://jp.physoc.org/cgi/content/full/jphysiol.2004.068403/DC1
and contains supplementary material consisting of two figures entitled: Uptake of Fluid phase markers into the mammary lumen from the interstitial space; and Electron microscope images of gold-labelled albumin after incubation with the ISSP.
This material can also be found at:
http://www.blackwellpublishing.com/products/journals/suppmat/tjp/tjp480/tjp480sm.htm
| References |
|---|
|
|
|---|
Apodaca G, Katz LA & Mostov KE (1994). Receptor-mediated trancytosis of IgA in MDCK cells is via apical recycling endosomes. J Cell Biol 125, 6788.
Barr VA, Scott LJ & Hubbard AL (1995). Immunoadsorption of hepatic vesicles carrying newly synthesized dipeptidyl peptidase IV and polymeric IgA receptor. J Biol Chem 270, 2783427844.
Beckstad M (1985). Optimal antigen localization in human tissue using aldehyde-fixed plastic-embedded sections. J Histochem Cytochem 33, 954958.[Abstract]
Berga SE (1984). Electrical potentials and cell-to-cell dye movement in mouse mammary gland during lactation. Am J Physiol 247, C2025.[Medline]
Bodega F, Zocchi L & Agostoni E (2002). Albumin transcytosis in mesothelium. Am J Physiol Lung Cell Mol Biol 282, L311.
Clague MJ (1998). Molecular aspects of the endocytic pathway. Biochem J 336(2), 271282.[Medline]
Clermont Y, Xia L, Rambourg A, Turner JD & Hermo L (1993). Structure of the Golgi apparatus in stimulated and nonstimulated acinar cells of mammary glands of the rat. Anat Rec 237, 308317.[CrossRef][Medline]
Davis SR, Hodgkinson SC, Prosser CG, Gluckman PD, Buonomo FC, Collier RJ et al. (1992). Effect of growth hormone treatment on the distribution of insulin-like growth factor-I between plasma and lymph of lactating sheep. J Endocrinol 132, 339344.[Abstract]
Elias JJ, Pitelka DR & Armstrong RC (1973). Changes in fat cell morphology during lactation in the mouse. Anat Rec 177, 533547.[CrossRef][Medline]
Geursen A & Grigor MR (1987). Serum albumin secretion in rat milk. J Physiol 391, 419427.
Ghitescu L, Fixman A, Simionescu M & Simionescu N (1986). Specific binding sites for albumin restricted to plasmalemmal vesicles of continous capillary endothelium: receptor-mediated transcytosis. J Cell Biol 102, 13041311.
Grigor MR, Bennett BL, Carne A & Cowan PE (1991). Whey proteins of the common brushtail possum (Trichosurus vulpecula): isolation, characterization and changes in concentration in milk during lactation of transferrin, alpha-lactalbumin and serum albumin. Comp Biochem Physiol B 98, 451459.[CrossRef][Medline]
Halsey JF, Mitchell C, Meyer R & Cebra JJ (1982). Metabolism of immunoglobulin A in lactating mice: origins of immunoglobulin A in milk. European J Immunol 12, 107112.[Medline]
Hendrickson BA, Rindisbacher L, Corthesy B, Kendall D, Waltz DA, Neutra MR et al. (1996). Lack of association of secretory component with IgA in J chain-deficient mice. J Immunol 157, 750754.[Abstract]
Igarashi N, Takeya R & Sato T (1993). An enzyme-linked immunosorbent assay for urinary albumin in patients with insulin-dependent diabetes mellitus. J Ped Endocrinol 6, 159164.[Medline]
Kim K-J & Malik AB (2003). Protein transport across the lung epithelial barrier. Am J Physiol Lung Cell Mol Physiol 264, L247259.
Kimm MH, Hardin JA & Gall DG (1997). Transport of albumin into the intestinal lumen of the rat. Can J Physiol Pharmacol 75, 193198.[CrossRef][Medline]
Kraehenbuhl J-P & Hunziker W (1998). Epithelial transcytosis of immunoglobulins. J Mammary Gland Biol Neoplasia 3, 289304.
Lamaze C & Schmid SL (1995). The emergence of clathrin-independent pinocytotic pathways. Curr Opin Cell Biol 118, 10031014.
Lascelles AK (1977). Role of the mammary gland and milk in immunology. In Comparative Aspects of Lactation, ed. Peaker M, pp. 241260. Academic Press, London.
Linzell JL & Peaker M (1974). Changes in colostrum composition and in the permeability of the mammary epithelium at about the time of parturition in the goat. J Physiol 243, 129151.
Lonnerdal B & Atkinson S (1995). Nitrogenous components of milk: A. Human milk proteins. In Handbook of Milk Composition, ed. Jensen RG, pp. 352368. Academic Press, San Diego.
Maugeais C, Braschi S, Ouguerram K, Maugeais P, Mahot P, Jactot B et al. (1997). Lipoprotein kinetics in patients with analbuminemia: Evidence for the role of serum albumin in controlling lipoprotein metabolism. Arterioscler Thromb Vasc Biol 17, 13691375.
Minshall RD, Tiruppathi C, Vogel SM & Malik AB (2002). Vesicle formation and trafficking in endothelial cells and regulation of endothelial barrier function. Histochem Cell Biol 117, 105112.[CrossRef][Medline]
Monks J, Huey PU, Hanson L, Eckel RH, Neville MC & Gavigan S (2001). A lipoprotein-containing particle is transferred from the serum across the mammary epithelium into the milk of lactating mice. J Lipid Res 42, 686696.
Mostov K (1993). Protein traffic in polarized epithelial cells: the polymeric immunoglobulin receptor as a model system. J Cell Sci 17, 2126.
Mukherjee S, Ghosh RN & Maxfield FR (1997). Endocytosis. Physiol Rev 77, 759803.
Nguyen DD, Beeman NG, Lewis MT, Schaack J & Neville MC (2000). Intraductal injection into the mouse mammary gland. In Methods in Mammary Gland Biology & Breast Cancer Research, ed. Ip MM and Asch BB, pp. 259270. Kluwer Academic/Plenum, New York.
Nguyen DD, Parlow AF & Neville MC (2001). Hormonal regulation of tight junction closure in the mouse mammary epithelium during the transition from pregnancy to lactation. J Endocrinol 170, 347356.[Abstract]
Pappenheimer JR, Renkin EM & Borrero LM (1951). Filtration, diffusion and molecular seiving through the pericapillary membranes. A contribution to the pore theory of capillary permeability. Am J Physiol 167, 1346.
Park DS, Lee H, Frank PG, Razani B, Nguyen AV, Parlow AF et al. (2002). Caveolin 1-deficient mice show accelerated mammary gland development during pregnancy, premature lactation, and hyperactivation of the Jak/STAT5a signaling cascade. Mol Biol Cell 13, 34163430.
Pol A, Ortega D & Enrich C (1997). Identification and distribution of proteins in isolated endosomal fractions of rat liver: involvement in endocytosis, recycling and transcytosis. Biochem J 323, 435443.[Medline]
Schanbacher FL & Smith KL (1975). Formation and role of unusual whey proteins and enzymes: Relation to mammary function. J Dairy Sci 58, 10481062.
Schnitzer JE & Bravo J (1993). High affinity binding, endocytosis, and degradation of conformationally modified albumins. Potential role of gp30 and gp18 as novel scavenger receptors. J Biol Chem 268, 75627570.
Schnitzer JE & Oh P (1994). Albondin-mediated capillary permeability to albumin. Differential role of receptors in endothelial transcytosis and endocytosis of native and modified albumins. J Biol Chem 269, 60726082.
Schnitzer JE, Oh P, Pinney E & Allard J (1994). Filipin-sensitive caveolae-mediated transport in endothelium: Reduced transcytosis, scavenger endocytosis and capillary permeability of select macromolecules. J Cell Biol 127, 12171232.
Schnitzer JE, Sung A, Horvat R & Bravo J (1992). Preferential interaction of albumin-binding proteins, gp30 and gp18, with conformationally modified albumins. Presence in many cells and tissues with a possible role in catabolism. J Biol Chem 267, 2454424553.
Swaisgood HE (1995). Protein and amino acid composition of bovine milk. In Handbook of Milk Composition, ed. Jensen RG, pp. 464467. Academic Press, San Diego.
Sztul ES, Howell KE & Palade GE (1983). Intracellular transport of secretory component and albumin in rat hepatocytes. J Cell Biol 97, 15821591.
Tuma PL & Hubbard AL (2003). Transcytosis: crossing cellular barriers. Physiol Rev 83, 871932.
Vogel SM, Minshall RD, Pilipovic M, Tiruppathi C & Malik AB (2001). Albumin uptake and transcytosis in endothelial cells in vivo induced by albumin-binding protein. Am J Physiol Lung Cell Mol Physiol 281, L15121522.
Zhang P, Sawicki V, Lewis A, Hanson L, Monks J & Neville MC (2000). The effect of serum iron concentration on iron secretion into mouse milk. J Physiol 522, 479491.
| Acknowledgements |
|---|
This article has been cited by other articles:
![]() |
J. R. Sabah, B. D. Schultz, Z. W. Brown, A. T. Nguyen, J. Reddan, and L. J. Takemoto Transcytotic Passage of Albumin through Lens Epithelial Cells Invest. Ophthalmol. Vis. Sci., March 1, 2007; 48(3): 1237 - 1244. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Lambot, P. Lybaert, A. Boom, J. Delogne-Desnoeck, A.M. Vanbellinghen, G. Graff, P. Lebrun, and S. Meuris Evidence for a Clathrin-Mediated Recycling of Albumin in Human Term Placenta Biol Reprod, July 1, 2006; 75(1): 90 - 97. [Abstract] [Full Text] [PDF] |
||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||